Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Watson Talks Up Prochieve And Global Expansion At Analyst Meeting

Executive Summary

Watson Pharmaceutical Inc.'s recent analyst meeting provided a substantial window on a company that is in the midst of a multi-year transformation, with insights into its growth strategy through 2013, but also with some potentially important qualifiers.
Advertisement

Related Content

Watson Pulls Prochieve From Guidance, But Pushes For Approval
Chief Executive Change At Teva Illustrates Diversification Emphasis At Major Generic Drug Makers
Can Watson Give Birth To A Pregnancy Franchise As It Helps Lay Lipitor To Rest?
The Return Of Big Pharma? 2011 Novel Approvals Could Show Payoff Of Licensing And Acquisition Strategies
The Return Of Big Pharma? 2011 Novel Approvals Could Show Payoff Of Licensing And Acquisition Strategies
The Last Days Of Lipitor: Morass Of Regulatory, Legal Issues Could Mean Few Early Generics
The Last Days Of Lipitor: Morass Of Regulatory, Legal Issues Could Mean Few Early Generics
The Return Of Big Pharma? 2011 Novel Approvals Could Show Payoff Of Licensing And Acquisition Strategies
As Launch Date Nears, Is Ranbaxy Exploring Talks To Monetize Lipitor First-launch Opportunity With Generic Rivals?
Watson Acquires Arrow Group And Expands Its Global Footprint

Topics

Advertisement
UsernamePublicRestriction

Register

PS053106

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel